AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research
Click Here to Manage Email Alerts
Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.
The award honors an individual who has made significant contributions to cancer research, whether it be via a single scientific discovery or through a body of work.
Such contributions — possible via research, leadership or mentorship — should have had a lasting impact on the field of cancer research and have demonstrated a lifetime commitment to progress against cancer.
Rosenberg is a senior investigator in NCI’s Center for Cancer Research, chief of the NCI Surgery Branch, head of the tumor immunology section, and professor of surgery at Uniformed Services University of Health Sciences and George Washington University School of Medicine and Health Sciences.
Rosenberg is receiving the award for a career with several notable achievements, starting with research that established interleukin-2 (IL-2) as the first FDA-approved cancer immunotherapy. IL-2 has since been approved as a treatment option for patients with metastatic renal cell carcinoma or metastatic melanoma.
He also helped establish basic principles involving cellular and genetic engineering as a pioneer in the field of adoptive cell therapy. Rosenberg’s research served as foundational pieces to the development of both tumor-infiltrating lymphocytes for the treatment of solid tumors and chimeric antigen receptor T-cell therapy for hematologic malignancies.
“Dr. Rosenberg’s innovative, groundbreaking research has revolutionized the scientific understanding of the immune response to cancer and resulted in the development of cancer immunotherapies and gene therapies that are saving countless lives around the world,” Margaret Foti, PhD, MD (hc), CEO of the AACR, said in a press release.
“Moreover, he has helped secure the future of the cancer immunotherapy field through his dedication to mentorship and his support of the next generation of cancer researchers,” she added. “We are very grateful for Dr. Rosenberg’s contributions and thrilled to celebrate his highly productive and impactful career with this prestigious award.”
Rosenberg received his undergraduate and medical degrees from Johns Hopkins University, before earning a doctorate in biophysics from Harvard University and completing his surgical residency at what is now Brigham and Women’s Hospital.
He has been an AACR member since 1971 and became a fellow of the AACR Academy in 2015.
Click Here to Manage Email Alerts